ciation of microbleeds with incident lacunes, and linear regression was used to investigate the relation between microbleeds and progression of WML volume. All analyses were adjusted for age, sex and the time interval between baseline and follow-up scanning. The analyses were repeated after additional adjustments for cardiovascular risk factors: blood pressures; total and high-density lipoprotein cholesterol; smoking; diabetes mellitus; lipid lowering, antihypertensive and antiplatelet medications, and apolipoprotein E ε4. The analyses involving WMLs were also adjusted for intracranial volume. Results: We found that pre-existing microbleeds in any location of the brain were related to a higher incidence of lacunes (odds ratio [OR] adjusted for age, sex and scan interval: 4.67; 95% confidence interval [CI]: 1.84-11.85). Pre-existing microbleeds were not related to progression of WML volume (mean difference in WML volume increase: -0.03; 95% CI: -0.15 to 0.09). Additional adjustments for cardiovascular risk factors did not change the results considerably. Incident microbleeds in any location of the brain were associated with a higher incidence of lacunes (OR: 9.18; 95% CI: 3.61-23.35), whereas only incident microbleeds located in cortico-subcortical regions were related to progression of WML volume (mean difference in WML volume in-
Introduction
Vascular brain pathology is highly prevalent in aging populations and may clinically manifest as stroke or dementia. Before the onset of clinical disease, vascular pathology accumulates over the course of several years, during which it can be visualized by magnetic resonance imaging (MRI) as lacunes of presumed vascular origin (henceforth lacunes) [1] , white matter lesions (WMLs) and cerebral microbleeds (CMBs) [2] .
Based on pathologic features, lacunes and WMLs are presumed to indicate an ischemic vascular pathology in the brain, whereas microbleeds are thought to represent a bleeding-prone state. Despite their different appearance on imaging, lacunes, WMLs and microbleeds very often co-occur in the brain [3] [4] [5] [6] . Moreover, the many shared risk factors for lacunes, WMLs and microbleeds suggest that these lesions are at least partly affected by common pathological mechanisms [4] [5] [6] [7] [8] [9] . Therefore, in the progression of vascular brain pathology, one would expect that one common pathological pathway ultimately diverges into two distinct pathways leading to the different phenotypes, i.e., ischemic and hemorrhagic events ( fig. 1 ). However, evidence in support of this 'diverging pathway' hypothesis is scarce [3, 10] . Hemorrhagic and ischemic brain lesions and their progression are often studied as separate entities and typically in clinical populations, even though both types of lesions are also highly prevalent in the general population [11] .
We have previously shown that, in a population-based setting, pre-existing microbleeds increase the risk of developing new microbleeds [12] . In addition, we showed that pre-existing ischemic lesions, i.e., lacunes and WMLs, were related to both the presence and incidence of CMBs [12] [13] [14] . Thus far, no study in the general population has explored the opposite association. Evidence for microbleeds predicting and simultaneously progressing with silent ischemic vascular lesions would strengthen the argument of a shared etiological pathway. We therefore investigated, in the population-based Rotterdam Scan Study, whether pre-existing microbleeds and incident microbleeds were related to incident lacunes and progression of WML volume.
Methods

Participants
The study was conducted as part of the population-based Rotterdam Scan Study [15] , a neuroimaging investigation embedded in the larger prospective Rotterdam Study [16] . Between 2005 and 2006, 1,375 nondemented study participants were randomly invited to undergo baseline brain MRI scanning. The institutional review board approved the study. A total of 146 participants were ineligible to undergo MRI (typically due to MRI contraindications). Of the 1,229 eligible participants at baseline, 1,062 (86.4%) underwent complete MRI scanning after informed consent was obtained. Subsequently, the participants were reinvited to undergo a repeat brain MRI between 2008 and 2010, i.e., 3-4 years after baseline. Of the 1,062 participants with baseline MRI examinations, 982 were eligible to participate in the follow-up scanning and 848 (86.4%) gave their written informed consent. Physical inabilities prohibited the completion of scanning in 14 individuals. Of the 834 complete scans, 3 had to be excluded because of artifacts, leaving a total of 831 scans for analysis. 
Assessment of MRI Markers of Cerebrovascular Disease
Both baseline and follow-up scanning were performed on a 1.5-tesla MRI scanner (GE Healthcare, Milwaukee, Wis., USA) [15] . The presence of MRI markers of cerebrovascular disease was rated by 1 of 5 trained research physicians. The raters were blinded to the clinical data. The presence, number and location of CMBs was rated on three-dimensional T2 * -weighted gradient-recalled echo MRI at both time points [13] . Baseline or follow-up scans that showed ≥ 1 CMBs were rated blinded for time point in a side-by-side comparison [12] . The participants were categorized into groups of individuals who had microbleeds in lobar brain regions only and individuals who had microbleeds in deep or infratentorial regions (regardless of the presence of lobar microbleeds). The presence of lacunes and cortical infarcts was rated on fluid-attenuated inversion recovery (FLAIR), proton density-weighted and T1-weighted sequences [13] . Participants with ≥ 1 infarcts at any of the two time points were included in a side-by-side comparison to assess the final number of infarcts on each scan. Lacunes were defined as focal lesions ≥ 3 and <15 mm in size with the same signal intensity as cerebrospinal fluid on all sequences and a hyperintense rim on FLAIR (when located supratentorially). Infarcts showing the involvement of gray matter were classified as cortical infarcts [13] . Quantitative measures of WML volume (in milliliters) and intracranial volume (in milliliters) were obtained at both time points, using validated automated postprocessing steps that included conventional k-nearest-neighbor brain tissue classification extended with WML segmentation [17, 18] .
Assessment of Cardiovascular Risk Factors
All participants were examined by trained personnel [16, 19] . We used standardized interviews as well as laboratory and physical examinations around the time of baseline MRI scanning to assess cardiovascular risk factors. Blood pressure measurements were averaged over 2 readings, measured on the right arm with a randomzero sphygmomanometer. Serum total and high-density lipoprotein cholesterol were determined using an automated enzymatic procedure [20] . Smoking habits were defined as 'ever' or 'never' smoking. Participants were considered diabetic if their fasting glucose levels were ≥ 7.0 mmol/l or if they used any glucose-lowering medication. The use of lipid-lowering and blood pressure-lowering medications was assessed by interviews during home visits. Information on antiplatelet medication use (i.e., aspirin or carbasalate calcium preparations) was obtained from automated pharmacy records and categorized as 'ever' versus 'never' used before MRI. Apolipoprotein E (APOE) genotyping was done on coded genomic DNA samples [21] , with allele frequencies being in Hardy-Weinberg equilibrium.
Data Analysis
We investigated the microbleed status dichotomously and by location (strictly lobar vs. no CMBs and deep or infratentorial vs. no CMBs), as described previously [13] . Additionally, we investigated categories of microbleed count, namely, single versus no CMBs and multiple versus no CMBs. Logistic regression models adjusted for age, sex and scan interval (in years) were used to investigate the association of pre-existing and incident microbleeds with incident lacunes. WML progression (in milliliters per year) was assessed by calculating the differences in lesion load volume (in milliliters) on baseline and follow-up scans and subsequently dividing this number by the time interval between the two scans (in years).
We applied linear regression models to investigate the association of pre-existing and incident microbleeds with progression of WML volume. All analyses of WMLs were adjusted for age, sex, scan interval and intracranial volume. The analyses were repeated after adjustment for cardiovascular risk factors, adjustment for APOE ε4 and, finally, after stratification by APOE ε4 carriership. Individuals with cortical infarcts at baseline or follow-up scanning were excluded from all analyses (n = 28) because tissue loss and the gliosis surrounding cortical infarctions may influence image registration to an extent that WML segmentation measures become unreliable. For the analyses of WMLs, an additional 27 scans had to be excluded due to segmentation errors in baseline or follow-up scans. The analyses were performed using the statistical software package SPSS version 21.0 (SPSS Inc., Chicago, Ill., USA), using an α value of 0.05.
Results
The characteristics of the study population are shown in table 1 . The mean age was 68.3 years, and 410 participants (51.1%) were women. Microbleeds were present in Data are presented as means ± SD unless specified otherwise. The following variables had missing data: systolic and diastolic blood pressure (n = 3), total and high-density lipoprotein cholesterol (n = 6), smoking (n = 8), diabetes mellitus (n = 11), lipid-lowering and antihypertensive medications (n = 8) and APOE genotype (n = 4).
a Values for WMLs are presented as medians with interquartile ranges in parentheses.
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Cerebrovasc Dis 2014;37:382-388 DOI: 10.1159/000362590 385 195 participants (24.3%) at baseline, and 78 (9.7%) developed ≥ 1 new microbleeds during follow-up. Incident microbleeds were located strictly in lobar regions in 49 participants (6.1%) and in deep or infratentorial brain regions in 29 (3.6%). At baseline, 59 participants (7.3%) had lacunes, and 20 (2.5%) developed ≥ 1 new lacunes. The median baseline volume of WMLs was 3.7 ml, and a median increase of 0.18 ml/year was seen during a mean scanning interval of 3.4 years. Table 2 shows the association between CMBs and incident lacunes. Pre-existing microbleeds, at any location in the brain, were related to incident lacunes. Although deep or infratentorial microbleeds were more strongly associated with incident lacunes after adjustment for cardiovascular risk factors (OR for incident lacunes: 6.10; 95% CI: 1.61-23.14), strictly lobar microbleeds were most strongly related to incident lacunes after adjusting for APOE ε4 carriership (OR: 4.79; 95% CI: 1.46-15.67). Also, incident microbleeds at any location in the brain were strongly associated with incident lacunes (OR: 9.18; 95% CI: 3.61-23.35). Adjusting for baseline WML volume did not alter these results (data not shown). Both single and multiple preexisting or incident microbleeds increased the risk of incident lacunes, and although the numbers were small, the associations were strongest for multiple incident microbleeds (online suppl. table 1; for all online suppl. material, see www.karger.com/doi/10.1159/000362590).
The association between CMBs and WML volume progression is shown in table 3 . Pre-existing microbleeds were not related to WML volume progression. However, the progression of strictly lobar microbleeds was strongly associated with the progression of WML volume (mean difference in WML volume increase: 0.41; 95% CI: 0.21-0.62). This was true for individuals with a single incident microbleed, but even more so for those with multiple strictly lobar incident microbleeds (online suppl. table 2). Adjusting for baseline lacunes did not alter these results (data not shown). Although statistical significance was not reached, it appeared that there was more WML volume progression in individuals with strictly lobar incident microbleeds who carried the APOE ε4 allele than in noncarriers (p interaction: 0.14; online suppl. table 3).
Discussion
In our longitudinal population-based study, we found that both pre-existing and incident microbleeds were related to incident lacunes and progression of WML volume. Strengths of our study are its population-based setting and the large number of participants with a follow-up scan. Also, we performed an identical MRI protocol on the same MRI scanner at both time points without software or hardware alterations to optimize comparability between scans over time. A possible limitation of the study is that selective dropout may have influenced our results as the participants who underwent follow-up MRI scanning were younger and healthier than those who refused or were ineligible to undergo a second MRI scanning. However, if present, selective dropout would have underestimated the true strength of the association between microbleeds and ischemic vascular lesions in our Values represent OR with 95% CI in parentheses for incident lacunes in participants with pre-existing and incident microbleeds compared with no microbleeds. Model 1: adjusted for age, sex and scan interval. Model 2: as model 1, additionally adjusted for blood pressures, total and high-density lipoprotein cholesterol, smoking, diabetes mellitus and lipid-lowering, antihypertensive and antiplatelet medications. Model 3: as model 1, additionally adjusted for APOE ε4 genotype. n = Number of participants with incident lacunes; N = total number of participants.
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Cerebrovasc Dis 2014;37:382-388 DOI: 10.1159/000362590 386 study because the individuals who would have dropped out would have been more likely to have a worse cardiovascular risk profile. As for the analysis stratified by APOE ε4, the sample size was rather small, and these results should be interpreted with caution.
We found that incident microbleeds, which pathologically correspond to hemorrhagic lesions [22] [23] [24] , related to an increased risk of progression of ischemic vascular lesions. This was particularly true for individuals with multiple incident microbleeds. Unfortunately, our study setting did not allow us to identify the chronological order of lesion occurrence. However, the co-occurrence of incident CMBs, incident lacunes and progression of WML volume does suggest that the accumulation of these vascular pathologies follows a common pathway, which may depend on shared pathophysiological mechanisms. Person-specific modifiable risk factors (e.g., oral anticoagulant drug use) or nonmodifiable risk factors (e.g., genetic variations) may then tilt individuals toward a final pathway of either major symptomatic hemorrhagic events or major symptomatic ischemic events.
We have previously shown that in preclinical asymptomatic individuals, pre-existing ischemic vascular lesions were related to the presence and incidence of microbleeds [13, 14] . Taken together with our current findings, this strengthens the suggestion of a common pathogenic pathway with a divergence for ischemic and hemorrhagic lesions. One point of note is that the progression of hemorrhagic and ischemic vascular brain lesions did not solely depend on shared cardiovascular risk factors, as adjusting for these factors did not change our findings. Although the underlying mechanism explaining this diverging pathway remains unclear, we speculate that advanced cerebral amyloid angiopathy (CAA) pathology or hypertensive arteriopathy may give rise to both incident CMBs and incident ischemic lesions. Additionally, in small vessel disease, impaired vessel tone and impaired autoregulation may lead to hypoperfusion after vessels rupture [1, 25, 26] . Finally, proinflammatory pathways may be triggered in the vasculopathy, advocating the synchronic progression of both hemorrhagic and ischemic lesions [27] . Interestingly, there are also observations from pathology suggesting that microbleeds themselves have an ischemic origin [28] . Microbleeds may not exclusively reflect extravasation of erythrocytes but may partly signify the inability of the aging brain to store ferritin iron released from ischemic damaged brain cells [28] .
Consistent evidence from observational and pathology studies implies that CAA is the prevailing pathology underlying microbleeds confined to cortico-subcortical (i.e., lobar) regions of the brain, whereas microbleeds located in deeper or infratentorial regions of the brain are more suggestive of hypertensive arteriopathy [13, 22, 29] . These observations have led to the assumption that depending on the location of microbleeds in the brain, and thus on their underlying pathology, microbleeds may differentially relate to ischemic small vessel lesions, i.e., lacunes or WMLs.
In the current study, we found that both pre-existing lobar and deep or infratentorial microbleeds increased the risk of incident lacunes. Also, the development of lobar microbleeds concurred with a higher progression of WML volume. In previous work, we showed that a higher WML load increased the risk of both deep or infratentorial and lobar microbleeds [12] , and that pre-existing microbleeds increased the risk of new microbleeds [12] . Taken together, these findings suggest that the pathology underlying microbleeds -be it hypertensive arteriopathy, amyloid angiopathy or a combination of both -may thus contribute to the progression of both ischemic and hemorrhagic lesions.
In CAA, vascular β-amyloid accumulates and might eventually lead to destruction of the vessel lumen, which leads to the development of lobar microbleeds [30] . However, vascular amyloid deposition may also cause stenosis, occlusion, loss of the contractile components of the vessel wall as well as impaired reactivity to physiologic stimulation [3] . The abnormal relaxation and constriction of small vessels may in turn contribute to repetitive hypoperfusion and, possibly, ischemic events [31] . Indeed, in patients with CAA-related hemorrhages, a progression of ischemic brain lesions on MRI has increasingly been recognized [9, 27, 32, 33] . Given our previous [12] [13] [14] and new findings, we might consider that in the general population, possible CAA-related microhemorrhages and ischemic lesions develop more steadily throughout the 'common pathway' . We did not find an association between deep or infratentorial CMBs and WML volume progression. As individuals with deep or infratentorial CMBs have higher WML volumes compared with those without microbleeds in these locations [12] [13] [14] , a possible 'ceiling effect' may be created in this group. This group nonetheless develops more lacunes, another likely ischemic manifestation.
In conclusion, we found support for a common underlying pathway in the development of ischemic and hemorrhagic vascular brain lesions. Furthermore, our findings suggest that CMBs may represent an imaging marker of active vasculopathy, which serves as a predictor of ischemic brain lesions.
